|
Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes.
|
Jan 2017
|
Am Soc Clin Oncol Educ Book
|
myelodysplastic syndromes (MDS)
|
|
Searching for a Light at the End of the Tunnel? Beyond Hypomethylating Agents in Myelodysplastic Syndromes.
|
Jan 2017
|
Am Soc Clin Oncol Educ Book
|
myelodysplastic syndromes (MDS)
|
|
How I Diagnose Low-Grade Myelodysplastic Syndromes
|
May 2020
|
American Journal of clinical Pathology
|
myelodysplastic syndromes (MDS)
|
|
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes
|
Nov 2019
|
American Journal of Hematology
|
myelodysplastic syndromes (MDS)
|
|
Complement inhibition in medicine: Hematology and beyond; complement inhibition in hematology: PNH and beyond
|
May 2023
|
American Journal of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management"
|
Mar 2021
|
American Journal of Hematology
|
myelodysplastic syndromes (MDS)
|
|
Paroxysmal nocturnal hemoglobinuria: Where we stand
|
May 2023
|
American Journal of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Efficacy and safety of the C5 inhibitor crovalimab in complement inhibitor-naive patients with PNH (COMMODORE 3): A multicenter, Phase 3, single-arm study
|
Jul 2023
|
American Journal of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Paroxysmal nocturnal hemoglobinuria: Where are we going
|
May 2023
|
American Journal of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Iron overload after complement inhibitor treatment of Paroxysmal Nocturnal Hemoglobinuria
|
Apr 2021
|
American Journal of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
